BioCryst Pharmaceuticals, Inc. (BCRX)
9.33
-0.23
(-2.41%)
USD |
NASDAQ |
Mar 27, 16:00
9.39
+0.06
(+0.64%)
After-Hours: 20:00
BioCryst Pharmaceuticals EPS Diluted (Quarterly) : 1.121 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 0.0199 |
| Lantheus Holdings, Inc. | 0.8156 |
| Revolution Medicines, Inc. | -1.855 |
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 245.84M |
| Revenue (Quarterly) | 406.56M |
| Total Expenses (Quarterly) | 160.71M |
| Enterprise Value | 2.542B |
| Gross Profit Margin (Quarterly) | 97.56% |
| Profit Margin (Quarterly) | 60.47% |
| Earnings Yield | 12.90% |
| Operating Earnings Yield | 16.72% |
| Normalized Earnings Yield | 13.49 |